Huanjie Yang
- Molecular Biology top 5%
- Oncology top 5%
- Complementary and alternative medicine top 0.5%
- Cancer Research top 5%
- Biomedical Engineering top 10%
- Topics
- Ubiquitin and proteasome pathways (20 papers)Natural Compounds in Disease Treatment (7 papers)Nanoplatforms for cancer theranostics (6 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Huanjie Yang
55 papers receiving 3.7k citations
Hit Papers
Peers
Comparison fields: 5 of 131
- Molecular Biology 2.0k
- Oncology 721
- Complementary and alternative medicine 638
- Cancer Research 505
- Biomedical Engineering 420
Countries citing papers authored by Huanjie Yang
This map shows the geographic impact of Huanjie Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huanjie Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huanjie Yang more than expected).
Fields of papers citing papers by Huanjie Yang
This network shows the impact of papers produced by Huanjie Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huanjie Yang. The network helps show where Huanjie Yang may publish in the future.
Co-authorship network of co-authors of Huanjie Yang
This figure shows the co-authorship network connecting the top 25 collaborators of Huanjie Yang. A scholar is included among the top collaborators of Huanjie Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huanjie Yang. Huanjie Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 6 | |
| 4 | 21 | |
| 5 | 31 | |
| 6 | 33 | |
| 7 | 72 | |
| 8 | 30 | |
| 9 | 67 | |
| 10 | 40 | |
| 11 | 1 | |
| 12 | 52 | |
| 13 | 23 | |
| 14 | 57 | |
| 15 | 10 | |
| 16 | 41 | |
| 17 | Disulfiram, a clinically used anti-alcoholism drug and copper-binding agent, induces apoptotic cell death in breast cancer cultures and xenografts via inhibition of the proteasome activity. | 17 |
| 18 | 123 | |
| 19 | 175 | |
| 20 | 20 |
About Huanjie Yang
Huanjie Yang is a scholar working on Applied Microbiology and Biotechnology, Complementary and alternative medicine and Cancer Research, having authored 57 papers that have together received 3.8k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (20 papers), Natural Compounds in Disease Treatment (7 papers) and Nanoplatforms for cancer theranostics (6 papers). The work is most often cited by research in Complementary and alternative medicine (638 citations), Toxicology (210 citations) and Applied Microbiology and Biotechnology (86 citations). Huanjie Yang has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Q. Ping Dou, Di Chen, Qiuzhi Cindy Cui, Xiao Yuan, Kai Li, Tak Hang Chan, Cheng‐Yan Xu, Liang Zhen, Zhaohua Miao and Kristin R. Landis‐Piwowar. Their work appears in journals such as PLoS ONE, Cancer Research and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.